3 small cap stars: Franklin covey, ligand Pharma and costar group

Franklin Covey offers visible and predictable growth in the $55B management training market, so don't sell the company's stock despite its surging price, says Michael Balkin, portfolio manager for the William Blair Small Cap Growth Fund. Balkin says